Combination dupilumab, abrocitinib effective in treating refractory pediatric AD
- Jeremy Visser
- Nov 6, 2024
- 1 min read
According to a recent study, a combination of dupilumab and abrocitinib is effective in treating refractory atopic dermatitis (AD) in pediatric patients.
Comentarios